Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival

Author: Rastellini C.   Salam A.   Kuddus R.   Aitouche A.   Subbotin V.   Braun M.   Leach R.   Peach R.   Fung J.J.   Starzl T.E.   Rao A.S.  

Publisher: Elsevier

ISSN: 0041-1345

Source: Transplantation Proceedings, Vol.31, Iss.1, 1999-02, pp. : 1242-1243

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content